Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
(Filled in some fields)
Line 3: Line 3:
 
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
 
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
 
|-
 
|-
−
!'''Disease'''!!'''Page Type'''!!'''Author (Date Assigned)'''!!'''Associate Editor'''
+
!'''Disease'''!!'''Page Type'''!!'''Author'''
 +
!'''Date Assigned'''!!'''Associate Editor'''
 
!Author Content Pending or Complete (Date Completed)
 
!Author Content Pending or Complete (Date Completed)
 
!Editor Reviewed (Date)
 
!Editor Reviewed (Date)
Line 9: Line 10:
 
|-
 
|-
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
 +
|
 
|Fabiola Quintero-Rivera (FQR)
 
|Fabiola Quintero-Rivera (FQR)
 
|PENDING
 
|PENDING
Line 16: Line 18:
 
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 23: Line 26:
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 30: Line 34:
 
|    Polycythaemia Vera  (PV)||Disease
 
|    Polycythaemia Vera  (PV)||Disease
 
|Gokce A. Toruner
 
|Gokce A. Toruner
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 37: Line 42:
 
|    Primary Myelofibrosis  (PMF)||Disease
 
|    Primary Myelofibrosis  (PMF)||Disease
 
|T. Niroshi  Senaratne
 
|T. Niroshi  Senaratne
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 44: Line 50:
 
|    Essential  Thrombocythaemia (ET)||Disease
 
|    Essential  Thrombocythaemia (ET)||Disease
 
|Rebecca Smith (trainee) + faculty TBD
 
|Rebecca Smith (trainee) + faculty TBD
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 51: Line 58:
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
 
|Mark Evans (trainee), Fabiola Quintero-Rivera
 
|Mark Evans (trainee), Fabiola Quintero-Rivera
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 58: Line 66:
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
 
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
 
|Mark Evans (trainee)+ Fabiola Quintero-Rivera
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 63: Line 72:
 
|
 
|
 
|-
 
|-
−
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
+
|'''''Mastocytosis'''''||'''''Overview'''''||
 +
| ||FQR
 
|
 
|
 
|
 
|
Line 70: Line 80:
 
|    Cutaneous  Mastocytosis||Disease
 
|    Cutaneous  Mastocytosis||Disease
 
|Thuy Phung
 
|Thuy Phung
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 77: Line 88:
 
|    Systemic Mastocytosis||Disease
 
|    Systemic Mastocytosis||Disease
 
|Shashi Shetty
 
|Shashi Shetty
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 84: Line 96:
 
|    Mast Cell Sarcoma||Disease
 
|    Mast Cell Sarcoma||Disease
 
|Thuy Phung
 
|Thuy Phung
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 90: Line 103:
 
|-
 
|-
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 96: Line 110:
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 102: Line 117:
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 108: Line 124:
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 114: Line 131:
 
|-
 
|-
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 122: Line 140:
 
|Disease
 
|Disease
 
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
 
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 130: Line 149:
 
|Disease
 
|Disease
 
|Lauren R. Crowson (trainee) + Daynna J. Wolff
 
|Lauren R. Crowson (trainee) + Daynna J. Wolff
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 136: Line 156:
 
|-
 
|-
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 142: Line 163:
 
|-
 
|-
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 148: Line 170:
 
|-
 
|-
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 154: Line 177:
 
|-
 
|-
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 160: Line 184:
 
|-
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 166: Line 191:
 
|-
 
|-
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 172: Line 198:
 
|-
 
|-
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
 
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
 +
|
 
|FQR
 
|FQR
 
|
 
|
Line 178: Line 205:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 184: Line 212:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 190: Line 219:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 196: Line 226:
 
|-
 
|-
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 202: Line 233:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 208: Line 240:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|Complete
 
|Complete
Line 214: Line 247:
 
|-
 
|-
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 220: Line 254:
 
|-
 
|-
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
 +
|
 
|FQR
 
|FQR
 
|PENDING
 
|PENDING
Line 225: Line 260:
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
Line 231: Line 267:
 
|-
 
|-
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
 +
|
 
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
 
|Complete
 
|Complete
Line 236: Line 273:
 
|
 
|
 
|-
 
|-
−
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH / MS
+
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)||JH / MS
+
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
 +
| ||JH / MS
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH / MS
+
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
 +
| ||JH / MS
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH / MS
+
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
 +
| ||JH / MS
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH / MS
+
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
 +
| ||JH / MS
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH / MS
+
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)||JH / MS
+
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
Line 272: Line 316:
 
|-
 
|-
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
 +
|
 
|JH / MS
 
|JH / MS
 
|Complete
 
|Complete
Line 277: Line 322:
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH / MS
+
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH / MS
+
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH / MS
+
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Need permission for figure?  Update WHO?
 
|Need permission for figure?  Update WHO?
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH / MS
+
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Add WHO reference
 
|Add WHO reference
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)||JH / MS
+
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH / MS
+
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)||JH / MS
+
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
−
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal||JH / MS
+
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)||JH / MS
+
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge||JH / MS
+
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH / MS
+
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH / MS
+
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH / MS
+
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH / MS
+
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH / MS
+
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH / MS
+
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)||JH / MS
+
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH / MS
+
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH / MS
+
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Need permission for figure?
 
|Need permission for figure?
 
|-
 
|-
−
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH / MS
+
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH / MS
+
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)||JH / MS
+
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH / MS
+
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)||JH / MS
+
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
−
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH / MS
+
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH / MS
+
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)||JH / MS
+
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|Check reference format
 
|Check reference format
 
|-
 
|-
−
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH / MS
+
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
 +
| ||JH / MS
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH / MS
+
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease||
 +
| ||JH / MS
 
|??
 
|??
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH / MS
+
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||
 +
| ||JH / MS
 
|??
 
|??
 
|
 
|
Line 460: Line 541:
 
|Disease
 
|Disease
 
|Kay Weng Choy + Greg Conboy (Monash Health)
 
|Kay Weng Choy + Greg Conboy (Monash Health)
 +
|
 
|JH / MS
 
|JH / MS
 
|Complete
 
|Complete
Line 468: Line 550:
 
|Disease
 
|Disease
 
|Daynna Wolff+Jessica Snider (Path Resident)
 
|Daynna Wolff+Jessica Snider (Path Resident)
 +
|
 
|JH / MS
 
|JH / MS
 
|PENDING
 
|PENDING
Line 476: Line 559:
 
|Disease
 
|Disease
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 
|Daynna Wolff+ Paige Woodham (Path Resident)
 +
|
 
|JH / MS
 
|JH / MS
 
|PENDING
 
|PENDING
Line 481: Line 565:
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
+
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
 +
| ||Yassmine Akkari (YA)
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
+
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
+
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
Line 502: Line 590:
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
 +
|
 
|YA
 
|YA
 
|PENDING
 
|PENDING
Line 507: Line 596:
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
Line 520: Line 611:
  
 
Lisa Smith + Yassmine Akkari
 
Lisa Smith + Yassmine Akkari
 +
|
 
|YA
 
|YA
 
|Complete
 
|Complete
Line 525: Line 617:
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
Line 536: Line 630:
 
|-
 
|-
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
 +
|
 
|YA
 
|YA
 
|Complete
 
|Complete
Line 541: Line 636:
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
+
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
+
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
+
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
+
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
 +
| ||YA
 
|
 
|
 
|
 
|
Line 569: Line 669:
 
|Disease
 
|Disease
 
|Helene Bruyere
 
|Helene Bruyere
 +
|
 
|YA
 
|YA
 
|PENDING
 
|PENDING
Line 574: Line 675:
 
|NON-WHO ENTITY
 
|NON-WHO ENTITY
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
+
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
 +
| ||Snehal Patel (SP)
 
|
 
|
 
|
 
|
Line 585: Line 688:
 
|-
 
|-
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 591: Line 695:
 
|-
 
|-
 
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 597: Line 702:
 
|-
 
|-
 
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 603: Line 709:
 
|-
 
|-
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
 +
|
 
|SP
 
|SP
 
|Complete
 
|Complete
Line 609: Line 716:
 
|-
 
|-
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 
|Hairy Cell Leukemia||Disease||Snehal Patel
 +
|
 
|SP
 
|SP
 
|Complete
 
|Complete
Line 615: Line 723:
 
|-
 
|-
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
 +
|
 
|SP
 
|SP
 
|Complete
 
|Complete
Line 621: Line 730:
 
|-
 
|-
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
 +
|
 
|SP
 
|SP
 
|Complete
 
|Complete
Line 627: Line 737:
 
|-
 
|-
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
 +
|
 
|SP
 
|SP
 
|Complete
 
|Complete
Line 633: Line 744:
 
|-
 
|-
 
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 639: Line 751:
 
|-
 
|-
 
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 
|   Waldenstrom  Macroglobulinemia||Disease||Honey Reddi
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 644: Line 757:
 
|
 
|
 
|-
 
|-
−
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
+
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
+
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mu Heavy Chain  Disease||Disease|| ||SP
+
|    Mu Heavy Chain  Disease||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Gamma Heavy Chain  Disease||Disease|| ||SP
+
|   Gamma Heavy Chain  Disease||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Alpha Heavy Chain  Disease||Disease|| ||SP
+
|    Alpha Heavy Chain  Disease||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 670: Line 788:
 
|-
 
|-
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 676: Line 795:
 
|-
 
|-
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 682: Line 802:
 
|-
 
|-
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 688: Line 809:
 
|-
 
|-
 
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 694: Line 816:
 
|-
 
|-
 
|    Plasmacytoma||Disease||Zhenya Tang
 
|    Plasmacytoma||Disease||Zhenya Tang
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 699: Line 822:
 
|
 
|
 
|-
 
|-
−
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
+
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|           Primary  Amyloidosis||Disease|| ||SP
+
|           Primary  Amyloidosis||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
+
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
+
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|         POEMS Syndrome||Disease|| ||SP
+
|         POEMS Syndrome||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|         TEMPI Syndrome||Disease|| ||SP
+
|         TEMPI Syndrome||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 730: Line 859:
 
|-
 
|-
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 735: Line 865:
 
|
 
|
 
|-
 
|-
−
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
+
|Nodal Marginal Zone Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 741: Line 872:
 
|-
 
|-
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 747: Line 879:
 
|-
 
|-
 
|Follicular Lymphoma||Disease||Ruthann Pfau
 
|Follicular Lymphoma||Disease||Ruthann Pfau
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 753: Line 886:
 
|-
 
|-
 
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 759: Line 893:
 
|-
 
|-
 
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 765: Line 900:
 
|-
 
|-
 
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 771: Line 907:
 
|-
 
|-
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 776: Line 913:
 
|
 
|
 
|-
 
|-
−
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
+
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
+
|Primary Cutaneous Follicle Centre Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 787: Line 926:
 
|-
 
|-
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 +
|
 
|SP
 
|SP
 
|PENDING - due 8/15/20
 
|PENDING - due 8/15/20
Line 793: Line 933:
 
|-
 
|-
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
 +
|
 
|SP
 
|SP
 
|PENDING - due 8/31/20
 
|PENDING - due 8/31/20
Line 799: Line 940:
 
|-
 
|-
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 
|    In Situ Mantle Cell  Neoplasia||Disease||Mahsa Khanlari
 +
|
 
|SP
 
|SP
 
|PENDING - due 8/15/20
 
|PENDING - due 8/15/20
Line 804: Line 946:
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
Line 810: Line 953:
 
|-
 
|-
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
 +
|
 
|Greg Corboy (GC)
 
|Greg Corboy (GC)
 
|PENDING
 
|PENDING
Line 815: Line 959:
 
|
 
|
 
|-
 
|-
−
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
+
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
+
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
+
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
+
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
+
|EBV-Positive Mucocutaneous Ulcer||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
+
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
+
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease|| ||GC
+
|Lymphomatoid Granulomatosis||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
+
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
+
|Intravascular Large B-cell Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
+
|ALK-Positive Large B-cell Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera||GC
+
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
 +
| ||GC
 
|Complete
 
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Primary Effusion Lymphoma||Disease|| ||GC
+
|Primary Effusion Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
+
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Multicentric Castleman  Disease||Disease|| ||GC
+
|   Multicentric Castleman  Disease||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
+
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
+
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Burkitt Lymphoma||Disease|| ||GC
+
|Burkitt Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
+
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
+
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
+
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
+
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
+
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
 +
| ||GC
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
+
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
 +
| ||Snehal Patel (SP)
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
+
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
 +
| ||SP
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
+
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
 +
| ||SP
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
+
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
 +
| ||SP
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Aggressive NK-cell Leukemia||Disease|| ||SP
+
|Aggressive NK-cell Leukemia||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||SP
+
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||SP
+
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
+
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
+
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
+
|    Severe Mosquito Bite  Allergy||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
+
|Adult T-cell Leukemia/Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
+
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 996: Line 1,176:
 
|-
 
|-
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,002: Line 1,183:
 
|-
 
|-
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,008: Line 1,190:
 
|-
 
|-
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,014: Line 1,197:
 
|-
 
|-
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,020: Line 1,204:
 
|-
 
|-
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,025: Line 1,210:
 
|
 
|
 
|-
 
|-
−
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
+
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
 +
| ||SP
 
|PENDING
 
|PENDING
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
+
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Mycosis Fungoides||Disease|| ||SP
+
|Mycosis Fungoides||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Sézary Syndrome||Disease|| ||SP
+
|Sézary Syndrome||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
+
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Lymphomatoid  Papulosis||Disease|| ||SP
+
|    Lymphomatoid  Papulosis||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
+
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
+
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
+
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
+
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
+
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
+
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
+
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
+
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,096: Line 1,295:
 
|-
 
|-
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,102: Line 1,302:
 
|-
 
|-
 
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,107: Line 1,308:
 
|
 
|
 
|-
 
|-
−
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
+
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||
 +
| ||SP
 
|
 
|
 
|
 
|
Line 1,113: Line 1,315:
 
|-
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,119: Line 1,322:
 
|-
 
|-
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,125: Line 1,329:
 
|-
 
|-
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
 +
|
 
|SP
 
|SP
 
|PENDING
 
|PENDING
Line 1,130: Line 1,335:
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
+
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
 +
| ||Associate Editor??
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
+
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
+
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
+
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
+
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
+
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
+
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
+
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Lymphomas Associated with HIV Infection||Disease|| ||
+
|Lymphomas Associated with HIV Infection||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
+
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
+
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
 +
| ||
 
|
 
|
 
|
 
|
Line 1,193: Line 1,410:
  
 
Fabiola Quintero-Rivera
 
Fabiola Quintero-Rivera
 +
|
 
|
 
|
 
|PENDING
 
|PENDING
Line 1,198: Line 1,416:
 
|
 
|
 
|-
 
|-
−
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
+
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|          Monomorphic  B-cell PTLD||Disease|| ||
+
|          Monomorphic  B-cell PTLD||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
+
|          Monomorphic  T/NK-cell PTLD||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
+
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
+
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
+
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Histiocytic Sarcoma||Disease|| ||
+
|Histiocytic Sarcoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
+
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Langerhans Cell  Histiocytosis||Disease|| ||
+
|   Langerhans Cell  Histiocytosis||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|   Langerhans Cell  Sarcoma||Disease|| ||
+
|   Langerhans Cell  Sarcoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Indeterminate Dendritic Cell Tumour||Disease|| ||
+
|Indeterminate Dendritic Cell Tumour||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
+
|Interdigitating Dendritic Cell Sarcoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Follicular Dendritic Cell Sarcoma||Disease|| ||
+
|Follicular Dendritic Cell Sarcoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
+
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Fibroblastic Reticular Cell Tumor||Disease|| ||
+
|Fibroblastic Reticular Cell Tumor||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
+
|Disseminated Juvenile Xanthogranuloma||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Erdheim-Chester Disease||Disease|| ||
+
|Erdheim-Chester Disease||Disease||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|
 
|
 
|
 
|-
 
|-
−
| || || ||
+
| || ||
 +
| ||
 
|
 
|
 
|
 
|

Revision as of 12:59, 7 August 2020

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
Disease Page Type Author Date Assigned Associate Editor Author Content Pending or Complete (Date Completed) Editor Reviewed (Date) Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera Fabiola Quintero-Rivera (FQR) PENDING
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera FQR Complete
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera FQR PENDING
    Polycythaemia Vera (PV) Disease Gokce A. Toruner FQR PENDING
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne FQR PENDING
    Essential Thrombocythaemia (ET) Disease Rebecca Smith (trainee) + faculty TBD FQR PENDING
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease Mark Evans (trainee), Fabiola Quintero-Rivera FQR PENDING
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Mark Evans (trainee)+ Fabiola Quintero-Rivera FQR PENDING
Mastocytosis Overview FQR
    Cutaneous Mastocytosis Disease Thuy Phung FQR PENDING
    Systemic Mastocytosis Disease Shashi Shetty FQR PENDING
    Mast Cell Sarcoma Disease Thuy Phung FQR PENDING
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff FQR PENDING
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff FQR Complete
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff FQR Complete
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding FQR Complete
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff FQR Complete
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff FQR Complete NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson (trainee) + Daynna J. Wolff FQR Complete NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang FQR Complete
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang FQR Complete
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang FQR Complete
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo FQR PENDING
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera FQR PENDING
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon FQR PENDING
Myelodysplastic Syndromes (MDS) Overview Teresa Smolarek? FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek FQR PENDING
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek FQR Complete
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek FQR Complete
    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek FQR PENDING
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek FQR PENDING
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek FQR Complete
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek FQR PENDING
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek FQR PENDING
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Jennelle Hodge (JH)/ Malini Sathanoori (MS) Complete
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou JH / MS Complete
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) JH / MS PENDING
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang JH / MS PENDING
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori JH / MS PENDING
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang JH / MS PENDING
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou JH / MS Complete
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) JH / MS Complete
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) JH / MS Complete
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke JH / MS Complete
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke JH / MS Complete
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty JH / MS Complete
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty JH / MS Complete
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge JH / MS Complete
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca JH / MS Complete Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge JH / MS Complete
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg Conboy (Monash Health) JH / MS Complete
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) JH / MS Complete Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Conboy (Monash Health) JH / MS Complete
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) JH / MS Complete
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang JH / MS Complete
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) JH / MS Complete Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal JH / MS Complete
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) JH / MS Complete
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge JH / MS Complete
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge JH / MS Complete
    Acute Myelomonocytic Leukemia Disease Fei Yang JH / MS Complete
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang JH / MS Complete
    Pure Erythroid Leukemia Disease Ash Yenamandra JH / MS Complete
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang JH / MS Complete
    Acute Basophilic Leukemia Disease Ash Yenamandra JH / MS Complete
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) JH / MS Complete
Myeloid Sarcoma Disease Fabiola Quintero-Rivera JH / MS Complete
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp JH / MS Complete Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley JH / MS Complete
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley JH / MS Complete
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) JH / MS Complete
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge JH / MS Complete
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) JH / MS Complete Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker JH / MS Complete
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker JH / MS Complete
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) JH / MS Complete Check reference format
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera JH / MS Complete
    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types Disease JH / MS ??
    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease JH / MS ??
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Conboy (Monash Health) JH / MS Complete NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) JH / MS PENDING NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) JH / MS PENDING NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) YA PENDING
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

YA Complete
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera YA Complete
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease YA
T-Lymphoblastic Leukemia/Lymphoma Overview YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease YA
NK-Lymphoblastic Leukemia/Lymphoma Disease YA
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Helene Bruyere YA PENDING NON-WHO ENTITY
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease Honey Reddi SP PENDING
       Monoclonal B-cell Lymphocytosis Disease Honey Reddi SP PENDING
B-cell Prolymphocytic Leukemia Disease Honey Reddi SP PENDING
Splenic Marginal Zone Lymphoma Disease Snehal Patel SP Complete Malini to review
Hairy Cell Leukemia Disease Snehal Patel SP Complete Malini to review
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel SP Complete Malini to review
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel SP Complete Malini to review
    Hairy Cell Leukemia Variant Disease Snehal Patel SP Complete Malini to review
Lymphoplasmacytic Lymphoma Disease Honey Reddi SP PENDING
   Waldenstrom Macroglobulinemia Disease Honey Reddi SP PENDING
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang SP PENDING
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang SP PENDING
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) SP PENDING
    Plasma Cell Myeloma Variants Disease Zhenya Tang SP PENDING
    Plasmacytoma Disease Zhenya Tang SP PENDING
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Zhenya Tang & Trainee SP PENDING
Nodal Marginal Zone Lymphoma Disease SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) SP PENDING
Follicular Lymphoma Disease Ruthann Pfau SP PENDING
    Testicular Follicular Lymphoma Disease Ruthann Pfau SP PENDING
    In Situ Follicular Neoplasia Disease Ruthann Pfau SP PENDING
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau SP PENDING
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) SP PENDING
Large B-cell Lymphoma with IRF4 Rearrangement Disease SP
Primary Cutaneous Follicle Centre Lymphoma Disease SP
Mantle Cell Lymphoma Disease Mahsa Khanlari SP PENDING - due 8/15/20
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease Mahsa Khanlari SP PENDING - due 8/31/20
    In Situ Mantle Cell Neoplasia Disease Mahsa Khanlari SP PENDING - due 8/15/20
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra Greg Corboy (GC) PENDING
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera GC Complete
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don SP PENDING
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don SP PENDING
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don SP PENDING
Aggressive NK-cell Leukemia Disease SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) SP PENDING
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) SP PENDING
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara SP PENDING
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) SP PENDING
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) SP PENDING
Hepatosplenic T-cell Lymphoma Disease Michelle Don SP PENDING
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease SP
Sézary Syndrome Disease SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview SP
    Lymphomatoid Papulosis Disease SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) SP PENDING
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) SP PENDING
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara SP PENDING
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara SP PENDING
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara SP PENDING
Hodgkin Lymphomas Overview Associate Editor??
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease
Classic Hodgkin Lymphoma Overview
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease
    Mixed Cellularity Classic Hodgkin Lymphoma Disease
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease
Immunodeficiency-Associated Lymphoproliferative Disorders Overview
Lymphomas Associated with HIV Infection Disease
Post-Transplant Lymphoproliferative Disorders Overview
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Anna Shestakova (trainee)+,

Fabiola Quintero-Rivera

PENDING
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview
          Monomorphic B-cell PTLD Disease
          Monomorphic T/NK-cell PTLD Disease
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease
Histiocytic and Dendritic Cell Neoplasms Overview
Histiocytic Sarcoma Disease
Tumors Derived From Langerhans Cells Overview
   Langerhans Cell Histiocytosis Disease
   Langerhans Cell Sarcoma Disease
Indeterminate Dendritic Cell Tumour Disease
Interdigitating Dendritic Cell Sarcoma Disease
Follicular Dendritic Cell Sarcoma Disease
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease
Fibroblastic Reticular Cell Tumor Disease
Disseminated Juvenile Xanthogranuloma Disease
Erdheim-Chester Disease Disease
Gene-Specific Pages
Gene Author Associate Editor Author Content

(Pending or Complete)

Editor Reviewed (Date) Notes
BCR Brian Davis Complete (8/10/18)
ABL1 Brian Davis Complete (4/16/19)
RUNX1 Brian Davis Complete (6/9/19)
RUNX1T1 Brian Davis Complete (5/23/19)
MYH11 Brian Davis Complete (8/6/18)
FLT3 Kay Weng Choy Complete (
NPM1 Kay Weng Choy Complete (
TP53 Kay Weng Choy Complete (
DNMT3A Kay Weng Choy Complete (
CEBPA Gordana Complete (
IDH1 Paul De Fazio Complete (
IDH2 Paul De Fazio Complete (
PML Brian Davis Complete (12/5/18)
RARA Brian Davis Complete (8/3/18)
ETV6 Brian Davis Complete (6/9/19)
KIT Brian Davis Complete (10/1/18)
CBFB Brian Davis Complete (8/2/18)
GATA2 Kay Weng Choy Complete (
PTEN Beth Pitel Pending
MLTT3
MECOM Brian Davis Pending
FGFR1(FLT2) Brian Davis Pending
KMT2A
DEK
NUP214
RBM15
MKL1
DDX41
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1
MN1
SF3A1
EP300
JARID2
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=8655"